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Background
Transfusion-associated graft-versus-host disease (TA-GVHD) is an immunological 
response between a donor’s transfused T cells and the recipient’s immune defense. The 
risk of TA-GVHD increases with relatively large transfusions of lymphocytes (e.g. 
transfusion in infants or granulocyte transfusion) or immunocompromised individuals. 
The risk of TA-GVHD is mitigated by irradiating cellular blood components to prevent 
donor T lymphocyte proliferation.  
Irradiation of cellular blood components is managed differently amongst institutions. 
Factors to consider in the irradiation process include technologist time. Technologists 
prepare and perform irradiation of the cellular blood products. This can be a labor 
intensive process. Cost is another factor that includes the cost of the irradiation 
indicators that are placed on the units and the labor in providing this service. 
Irradiation also shortens the shelf life of the cellular blood component to 28 days. If the 
shelf life was less than 28 days then irradiation does not extend the shelf life to 28 days 
(e.g. shelf life 14 days, post-irradiation remains 14 days). At Thomas Jefferson 
University Hospital, the Blood Bank irradiates blood products only upon request, then 
reviews the initial orders to determine if irradiation is indeed indicated. The decision 
whether irradiation is appropriate is determined by having medical coverage review the 
requests. 
Review of Inappropriate Orders
Irradiated blood product orders flagged for medical coverage review from July 2016 to 
March 2017 revealed 34 of the 55 orders were inappropriate. For each incorrect order, 
clinician name, clinician service, hospital unit, transfusion indications, and reason for 
irradiation were recorded. The inappropriate orders were submitted by 31 clinicians 
(24 medicine residents, two anesthesia residents, two otolaryngology residents, two 
nurse practitioners, and one attending physician). Three clinicians submitted two 
inappropriate irradiation orders. The clinicians ordered the irradiated cellular blood 
products because the patient had a history of cancer or was on immunosuppressive 
therapy. Some clinicians accidentally requested irradiated cellular blood products. 
Between March 1, 2017 and May 1, 2017, two orders for irradiated cellular blood 
products were flagged for medical coverage review. In one of those requests, irradiated 
cellular blood products were not indicated.
Interventions to Decrease Inappropriate Orders
Two interventions were undertaken to decrease the number of inappropriate 
irradiation orders. 
A polite and professional email was sent to the clinicians who submitted the 
inappropriate irradiation orders from July 2016 to March 2017. The email informed the 
clinician that they submitted an inappropriate irradiation order, provided them with a 
table of irradiation blood product indications, and additional resources. This email was 
sent on February 27, 2017. 
Discussion
Next Steps 
• Dr. Julie Karp, Associate Director of the Thomas Jefferson University Blood Bank, 
will give an educational lecture to the Department of Medicine residents on blood 
products (including irradiated cellular blood products) on June 13, 2017 
• Irradiated cellular blood product orders will be reviewed to determine if the number 
of inappropriate orders decrease over time.  
Possible Further Interventions 
• Email all Jefferson residents informing them of the indications for irradiated 
cellular blood products.  
• Email Jefferson faculty informing them of the indications for irradiated cellular 
blood products.  
• Present the findings of this research and the indications for irradiated cellular blood 
products to Jefferson residents at seminars, conferences, or meetings. 
Limitations 
• Only the clinician who submitted the inappropriate irradiation order was contacted, 
not the entire care team. 
• The preliminary post-intervention data may not be representative since residents 
gain experience during the year.  
• Only one year of inappropriate orders were reviewed.  
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Objective
Our goal is to educate house staff on the indications for irradiated blood products. We 
hope to reduce the number of inappropriate irradiation orders to less than 50% of the 
total orders for irradiated blood products and to be followed up over time.
A pocket card was also created. The card contained a table of indications for irradiated 
cellular blood products and contact information for the Jefferson Blood Bank to 
encourage collaboration between house staff and the Blood Bank. The card will be 
distributed on June 13, 2017 to Internal Medicine house staff. 
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